Key Takeaways
- • Inflexion Private Equity is acquiring Primed Group from Paragon Partners, marking Inflexion's sixth investment in the DACH region and third healthcare deal in that geography.
- • Primed Group operates HA2, a large-scale medical sterilization platform, and manufactures certified single-use medical consumables, serving hospitals and medical facilities across more than 70 countries.
- • Inflexion has appointed healthcare executives Wolfgang Suessle and Justin Barnes to Primed's board to support value creation and operational improvements following the acquisition.
- • The deal reinforces Inflexion's strategic focus on healthcare assets in continental Europe, following prior investments in Proteros and Tierarzt Plus Partner in the DACH region.
Summary
Inflexion Private Equity has agreed to acquire Primed Group from existing owner Paragon Partners, expanding its healthcare portfolio in the DACH region (Germany, Austria, and Switzerland). Primed Group is a manufacturer of certified single-use medical consumables and operates HA2, a large-scale sterilization platform that serves a geographically dispersed customer base of hospitals and medical facilities across more than 70 countries.
The transaction represents Inflexion's sixth investment in the DACH region and its third healthcare-focused deal in that market, demonstrating a sustained commitment to the healthcare sector in continental Europe. The firm's prior healthcare investments in the region include stakes in Proteros and Tierarzt Plus Partner, signaling an established investment thesis around healthcare infrastructure and medical services.
To support the acquisition and drive value creation, Inflexion has appointed two seasoned healthcare executives to Primed's board: Wolfgang Suessle and Justin Barnes. Their appointments indicate the firm's intention to leverage operational expertise and healthcare sector knowledge to enhance the platform's competitive positioning and growth trajectory following the transaction.
The transaction represents Inflexion's sixth investment in the DACH region and its third healthcare-focused deal in that market, demonstrating a sustained commitment to the healthcare sector in continental Europe. The firm's prior healthcare investments in the region include stakes in Proteros and Tierarzt Plus Partner, signaling an established investment thesis around healthcare infrastructure and medical services.
To support the acquisition and drive value creation, Inflexion has appointed two seasoned healthcare executives to Primed's board: Wolfgang Suessle and Justin Barnes. Their appointments indicate the firm's intention to leverage operational expertise and healthcare sector knowledge to enhance the platform's competitive positioning and growth trajectory following the transaction.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.